POC Cardiovascular Diagnostic Market by Type and Application - Global Industry Analysis & Forecast to 2027
Published On : October 2019 Pages : 160 Category: Pharma & Healthcare Report Code : HC106526
POC Cardiovascular Diagnostic Market by Type (Diagnostic Equipment, Diagnostic Reagents) Application (Clinic, Hospital, Other) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The POC Cardiovascular Diagnostic Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Point of-care (POC) testing, also called close patient testing or remote testing, is a fast and helpful approach to test a patient outside of a research facility, be it in a GP's center, an emergency vehicle, the home, the field, or in the clinic. Despite the fact that the advantages of POC cardiovascular testing have been all around reported, numerous clinics still utilize focal workstations to process tests or info results, and this methodology is a long way from optimal. The boom in POC testing today is for the most part being driven by wearable micro sensors and lab-on-a-chip innovation.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global POC Cardiovascular Diagnostic Market size market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Abbott
- Siemens
- Biomerieux
- F. Hoffmann-La Roche
- Danaher
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· POC Cardiovascular Diagnostic Market , By Type, Estimates and Forecast, 2017-2027 ($Million)
o Diagnostic Equipment
o Diagnostic Reagents
· POC Cardiovascular Diagnostic Market , By Application, Estimates and Forecast, 2017-2027 ($Million)
o Clinic
o Hospital
o Other
· POC Cardiovascular Diagnostic Market , By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Abbott
o Siemens
o Biomerieux
o F. Hoffmann-La Roche
o Danaher
· POC Cardiovascular Diagnostic Market , By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America POC Cardiovascular Diagnostic Market , By Country
o U.S. POC Cardiovascular Diagnostic Market
o Canada POC Cardiovascular Diagnostic Market
o Mexico POC Cardiovascular Diagnostic Market
o Europe
§ Europe POC Cardiovascular Diagnostic Market , By Country
· Germany POC Cardiovascular Diagnostic Market
o UK POC Cardiovascular Diagnostic Market
o France POC Cardiovascular Diagnostic Market
o Russia POC Cardiovascular Diagnostic Market
o Italy POC Cardiovascular Diagnostic Market
o Rest of Europe POC Cardiovascular Diagnostic Market
o Asia-Pacific
§ Asia-Pacific POC Cardiovascular Diagnostic Market , By Country
o China POC Cardiovascular Diagnostic Market
o Japan POC Cardiovascular Diagnostic Market
o South Korea POC Cardiovascular Diagnostic Market
o India POC Cardiovascular Diagnostic Market
o Southeast Asia POC Cardiovascular Diagnostic Market
o Rest of Asia-Pacific POC Cardiovascular Diagnostic Market
o South America
§ South America POC Cardiovascular Diagnostic Market
o Brazil POC Cardiovascular Diagnostic Market
o Argentina POC Cardiovascular Diagnostic Market
o Columbia POC Cardiovascular Diagnostic Market
o Rest of South America POC Cardiovascular Diagnostic Market
o Middle East and Africa
§ Middle East and Africa POC Cardiovascular Diagnostic Market
o Saudi Arabia POC Cardiovascular Diagnostic Market
o UAE POC Cardiovascular Diagnostic Market
o Egypt POC Cardiovascular Diagnostic Market
o Nigeria POC Cardiovascular Diagnostic Market
o South Africa POC Cardiovascular Diagnostic Market
o Rest of MEA POC Cardiovascular Diagnostic Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. POC Cardiovascular Diagnostic Market, By Type
5.1. Introduction
5.2. Global POC Cardiovascular Diagnostic Revenue and Market Share by Type (2017-2027)
5.2.1. Global POC Cardiovascular Diagnostic Revenue and Revenue Share by Type (2017-2027)
5.3. Diagnostic Equipment
5.3.1. Global Diagnostic Equipment Revenue and Growth Rate (2017-2027)
5.4. Diagnostic Reagents
5.4.1. Global Diagnostic Reagents Revenue and Growth Rate (2017-2027)
6. POC Cardiovascular Diagnostic Market, By Application
6.1. Introduction
6.2. Global POC Cardiovascular Diagnostic Revenue and Market Share by Application (2017-2027)
6.2.1. Global POC Cardiovascular Diagnostic Revenue and Revenue Share by Application (2017-2027)
6.3. Clinic
6.3.1. Global Clinic Revenue and Growth Rate (2017-2027)
6.4. Hospital
6.4.1. Global Hospital Revenue and Growth Rate (2017-2027)
6.5. Other
6.5.1. Global Other Revenue and Growth Rate (2017-2027)
7. POC Cardiovascular Diagnostic Market, By Region
7.1. Introduction
7.2. Global POC Cardiovascular Diagnostic Revenue and Market Share by Regions
7.2.1. Global POC Cardiovascular Diagnostic Revenue by Regions (2017-2027)
7.3. North America POC Cardiovascular Diagnostic by Countries
7.3.1. North America POC Cardiovascular Diagnostic Revenue and Growth Rate (2017-2027)
7.3.2. North America POC Cardiovascular Diagnostic Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe POC Cardiovascular Diagnostic by Countries
7.4.1. Europe POC Cardiovascular Diagnostic Revenue and Growth Rate (2017-2027)
7.4.2. Europe POC Cardiovascular Diagnostic Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific POC Cardiovascular Diagnostic by Countries
7.5.1. Asia-Pacific POC Cardiovascular Diagnostic Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific POC Cardiovascular Diagnostic Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America POC Cardiovascular Diagnostic by Countries
7.6.1. South America POC Cardiovascular Diagnostic Revenue and Growth Rate (2017-2027)
7.6.2. South America POC Cardiovascular Diagnostic Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa POC Cardiovascular Diagnostic by Countries
7.7.1. Middle East and Africa POC Cardiovascular Diagnostic Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa POC Cardiovascular Diagnostic Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. Abbott
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Siemens
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Biomerieux
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. F. Hoffmann-La Roche
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Danaher
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
9. POC Cardiovascular Diagnostic Market Forecast (2017-2027)
9.1. Global POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2027)
9.2. POC Cardiovascular Diagnostic Market Forecast by Regions (2017-2027)
9.2.1. North America POC Cardiovascular Diagnostic Market Forecast (2017-2027)
9.2.1.1. United States POC Cardiovascular Diagnostic Market Forecast (2017-2027)
9.2.1.2. Canada POC Cardiovascular Diagnostic Market Forecast (2017-2027)
9.2.1.3. Mexico POC Cardiovascular Diagnostic Market Forecast (2017-2027)
9.2.2. Europe POC Cardiovascular Diagnostic Market Forecast (2017-2027)
9.2.2.1. Germany POC Cardiovascular Diagnostic Market Forecast (2017-2027)
9.2.2.2. France POC Cardiovascular Diagnostic Market Forecast (2017-2027)
9.2.2.3. UK POC Cardiovascular Diagnostic Market Forecast (2017-2027)
9.2.2.4. Russia POC Cardiovascular Diagnostic Market Forecast (2017-2027)
9.2.2.5. Italy POC Cardiovascular Diagnostic Market Forecast (2017-2027)
9.2.2.6. Rest of Europe POC Cardiovascular Diagnostic Market Forecast (2017-2027)
9.2.3. Asia-Pacific POC Cardiovascular Diagnostic Market Forecast (2017-2027)
9.2.3.1. China POC Cardiovascular Diagnostic Market Forecast (2017-2027)
9.2.3.2. Japan POC Cardiovascular Diagnostic Market Forecast (2017-2027)
9.2.3.3. Korea POC Cardiovascular Diagnostic Market Forecast (2017-2027)
9.2.3.4. India POC Cardiovascular Diagnostic Market Forecast (2017-2027)
9.2.3.5. Southeast Asia POC Cardiovascular Diagnostic Market Forecast (2017-2027)
9.2.3.6. Rest of Asia-Pacific POC Cardiovascular Diagnostic Market Forecast (2017-2027)
9.2.4. South America POC Cardiovascular Diagnostic Market Forecast (2017-2027)
9.2.4.1. Brazil POC Cardiovascular Diagnostic Market Forecast (2017-2027)
9.2.4.2. Argentina POC Cardiovascular Diagnostic Market Forecast (2017-2027)
9.2.4.3. Columbia POC Cardiovascular Diagnostic Market Forecast (2017-2027)
9.2.4.4. Rest of South America POC Cardiovascular Diagnostic Market Forecast (2017-2027)
9.2.5. Middle East and Africa POC Cardiovascular Diagnostic Market Forecast (2017-2027)
9.2.5.1. Saudi Arabia POC Cardiovascular Diagnostic Market Forecast (2017-2027)
9.2.5.2. United Arab Emirates POC Cardiovascular Diagnostic Market Forecast (2017-2027)
9.2.5.3. Egypt POC Cardiovascular Diagnostic Market Forecast (2017-2027)
9.2.5.4. Nigeria POC Cardiovascular Diagnostic Market Forecast (2017-2027)
9.2.5.5. South Africa POC Cardiovascular Diagnostic Market Forecast (2017-2027)
9.2.5.6. Turkey POC Cardiovascular Diagnostic Market Forecast (2017-2027)
9.2.5.7. Rest of Middle East and Africa POC Cardiovascular Diagnostic Market Forecast (2017-2027)
9.3. POC Cardiovascular Diagnostic Market Forecast by Type (2017-2027)
9.3.1. POC Cardiovascular Diagnostic Forecast by Type (2017-2027)
9.3.2. POC Cardiovascular Diagnostic Market Share Forecast by Type (2017-2027)
9.4. POC Cardiovascular Diagnostic Market Forecast by Application (2017-2027)
9.4.1. POC Cardiovascular Diagnostic Forecast by Application (2017-2027)
9.4.2. POC Cardiovascular Diagnostic Market Share Forecast by Application (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States POC Cardiovascular Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada POC Cardiovascular Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico POC Cardiovascular Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany POC Cardiovascular Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure France POC Cardiovascular Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK POC Cardiovascular Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia POC Cardiovascular Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy POC Cardiovascular Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe POC Cardiovascular Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure China POC Cardiovascular Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan POC Cardiovascular Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea POC Cardiovascular Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure India POC Cardiovascular Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia POC Cardiovascular Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific POC Cardiovascular Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil POC Cardiovascular Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina POC Cardiovascular Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia POC Cardiovascular Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America POC Cardiovascular Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia POC Cardiovascular Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates POC Cardiovascular Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt POC Cardiovascular Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria POC Cardiovascular Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa POC Cardiovascular Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey POC Cardiovascular Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa POC Cardiovascular Diagnostic Revenue (Million USD) and Growth Rate (2017-2025)
Table Global POC Cardiovascular Diagnostic Revenue and Revenue Share by Type (2017-2018)
Figure Global Diagnostic Equipment Revenue and Growth Rate (2017-2018)
Figure Global Diagnostic Reagents Revenue and Growth Rate (2017-2018)
Table Global POC Cardiovascular Diagnostic Revenue and Revenue Share by Application (2017-2018)
Figure Global Clinic Revenue and Growth Rate (2017-2018)
Figure Global Hospital Revenue and Growth Rate (2017-2018)
Figure Global Other Revenue and Growth Rate (2017-2018)
Table Global POC Cardiovascular Diagnostic Revenue by Regions (2017-2018)
Figure North America POC Cardiovascular Diagnostic Growth Rate (2017-2018)
Figure North America POC Cardiovascular Diagnostic Revenue and Growth Rate (2017-2018)
Figure North America POC Cardiovascular Diagnostic by Countries (2017-2018)
Figure North America POC Cardiovascular Diagnostic Revenue (Million USD) by Countries (2017-2018)
Figure United States POC Cardiovascular Diagnostic Growth Rate (2017-2018)
Figure United States POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada POC Cardiovascular Diagnostic Growth Rate (2017-2018)
Figure Canada POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico POC Cardiovascular Diagnostic Growth Rate (2017-2018)
Figure Mexico POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe POC Cardiovascular Diagnostic Growth Rate (2017-2018)
Figure Europe POC Cardiovascular Diagnostic Revenue and Growth Rate (2017-2018)
Figure Europe POC Cardiovascular Diagnostic by Countries (2017-2018)
Figure Europe POC Cardiovascular Diagnostic Revenue (Million USD) by Countries (2017-2018)
Figure Germany POC Cardiovascular Diagnostic Growth Rate (2017-2018)
Figure Germany POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France POC Cardiovascular Diagnostic Growth Rate (2017-2018)
Figure France POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK POC Cardiovascular Diagnostic Growth Rate (2017-2018)
Figure UK POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia POC Cardiovascular Diagnostic Growth Rate (2017-2018)
Figure Russia POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy POC Cardiovascular Diagnostic Growth Rate (2017-2018)
Figure Italy POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe POC Cardiovascular Diagnostic Growth Rate (2017-2018)
Figure Rest of Europe POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific POC Cardiovascular Diagnostic Growth Rate (2017-2018)
Figure Asia-Pacific POC Cardiovascular Diagnostic Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific POC Cardiovascular Diagnostic by Countries (2017-2018)
Figure Asia-Pacific POC Cardiovascular Diagnostic Revenue (Million USD) by Countries (2017-2018)
Figure China POC Cardiovascular Diagnostic Growth Rate (2017-2018)
Figure China POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan POC Cardiovascular Diagnostic Growth Rate (2017-2018)
Figure Japan POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea POC Cardiovascular Diagnostic Growth Rate (2017-2018)
Figure Korea POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India POC Cardiovascular Diagnostic Growth Rate (2017-2018)
Figure India POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia POC Cardiovascular Diagnostic Growth Rate (2017-2018)
Figure Southeast Asia POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific POC Cardiovascular Diagnostic Growth Rate (2017-2018)
Figure Rest of Asia-Pacific POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America POC Cardiovascular Diagnostic Growth Rate (2017-2018)
Figure South America POC Cardiovascular Diagnostic Revenue and Growth Rate (2017-2018)
Figure South America POC Cardiovascular Diagnostic by Countries (2017-2018)
Figure South America POC Cardiovascular Diagnostic Revenue (Million USD) by Countries (2017-2018)
Figure Brazil POC Cardiovascular Diagnostic Growth Rate (2017-2018)
Figure Brazil POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina POC Cardiovascular Diagnostic Growth Rate (2017-2018)
Figure Argentina POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia POC Cardiovascular Diagnostic Growth Rate (2017-2018)
Figure Columbia POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America POC Cardiovascular Diagnostic Growth Rate (2017-2018)
Figure Rest of South America POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa POC Cardiovascular Diagnostic Growth Rate (2017-2018)
Figure Middle East and Africa POC Cardiovascular Diagnostic Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa POC Cardiovascular Diagnostic by Countries (2017-2018)
Figure Middle East and Africa POC Cardiovascular Diagnostic Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia POC Cardiovascular Diagnostic Growth Rate (2017-2018)
Figure Saudi Arabia POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates POC Cardiovascular Diagnostic Growth Rate (2017-2018)
Figure United Arab Emirates POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt POC Cardiovascular Diagnostic Growth Rate (2017-2018)
Figure Egypt POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria POC Cardiovascular Diagnostic Growth Rate (2017-2018)
Figure Nigeria POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa POC Cardiovascular Diagnostic Growth Rate (2017-2018)
Figure South Africa POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey POC Cardiovascular Diagnostic Growth Rate (2017-2018)
Figure Turkey POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa POC Cardiovascular Diagnostic Growth Rate (2017-2018)
Figure Rest of Middle East and Africa POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2017-2018)
Table Abbott POC Cardiovascular Diagnostic Financial Overview
Table Siemens POC Cardiovascular Diagnostic Financial Overview
Table Biomerieux POC Cardiovascular Diagnostic Financial Overview
Table F. Hoffmann-La Roche POC Cardiovascular Diagnostic Financial Overview
Table Danaher POC Cardiovascular Diagnostic Financial Overview
Figure Global POC Cardiovascular Diagnostic Revenue (Millions USD) and Growth Rate (2018-2025)
Table POC Cardiovascular Diagnostic Market Forecast by Regions (2018-2025)
Figure North America POC Cardiovascular Diagnostic Market Forecast (2018-2025)
Figure United States POC Cardiovascular Diagnostic Market Forecast (2018-2025)
Figure Canada POC Cardiovascular Diagnostic Market Forecast (2018-2025)
Figure Mexico POC Cardiovascular Diagnostic Market Forecast (2018-2025)
Figure Europe POC Cardiovascular Diagnostic Market Forecast (2018-2025)
Figure Germany POC Cardiovascular Diagnostic Market Forecast (2018-2025)
Figure France POC Cardiovascular Diagnostic Market Forecast (2018-2025)
Figure UK POC Cardiovascular Diagnostic Market Forecast (2018-2025)
Figure Russia POC Cardiovascular Diagnostic Market Forecast (2018-2025)
Figure Italy POC Cardiovascular Diagnostic Market Forecast (2018-2025)
Figure Rest of Europe POC Cardiovascular Diagnostic Market Forecast (2018-2025)
Figure Asia-Pacific POC Cardiovascular Diagnostic Market Forecast (2018-2025)
Figure China POC Cardiovascular Diagnostic Market Forecast (2018-2025)
Figure Japan POC Cardiovascular Diagnostic Market Forecast (2018-2025)
Figure Korea POC Cardiovascular Diagnostic Market Forecast (2018-2025)
Figure India POC Cardiovascular Diagnostic Market Forecast (2018-2025)
Figure Southeast Asia POC Cardiovascular Diagnostic Market Forecast (2018-2025)
Figure Rest of Asia-Pacific POC Cardiovascular Diagnostic Market Forecast (2018-2025)
Figure South America POC Cardiovascular Diagnostic Market Forecast (2018-2025)
Figure Brazil POC Cardiovascular Diagnostic Market Forecast (2018-2025)
Figure Argentina POC Cardiovascular Diagnostic Market Forecast (2018-2025)
Figure Columbia POC Cardiovascular Diagnostic Market Forecast (2018-2025)
Figure Rest of South America POC Cardiovascular Diagnostic Market Forecast (2018-2025)
Figure Middle East and Africa POC Cardiovascular Diagnostic Market Forecast (2018-2025)
Figure Saudi Arabia POC Cardiovascular Diagnostic Market Forecast (2018-2025)
Figure United Arab Emirates POC Cardiovascular Diagnostic Market Forecast (2018-2025)
Figure Egypt POC Cardiovascular Diagnostic Market Forecast (2018-2025)
Figure Nigeria POC Cardiovascular Diagnostic Market Forecast (2018-2025)
Figure South Africa POC Cardiovascular Diagnostic Market Forecast (2018-2025)
Figure Turkey POC Cardiovascular Diagnostic Market Forecast (2018-2025)
Figure Rest of Middle East and Africa POC Cardiovascular Diagnostic Market Forecast (2018-2025)
Figure Global POC Cardiovascular Diagnostic Forecast by Type (2018-2025)
Figure Global POC Cardiovascular Diagnostic Market Share Forecast by Type (2018-2025)
Figure Global POC Cardiovascular Diagnostic Forecast by Type (2018-2025)
Figure Global POC Cardiovascular Diagnostic Forecast by Application (2018-2025)
Figure Global POC Cardiovascular Diagnostic Market Share Forecast by Application (2018-2025)
Figure Global POC Cardiovascular Diagnostic Forecast by Application (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|